You Are On:
EQUITY
Equity Analysis
  Price
    Gainers & Losers
    Out & Under Performers
    Only Buyers & Sellers
     Advances & Declines
     New Highs & Lows
     Weightage
     5 Day's Up & Down
  Volume
  Analysis
News Analysis
Corporate Info
Corporate Action
Other Market
Cash Flow    
Vivimed Labs Ltd.
 
BSE Code
ISIN Demat
Book Value
NSE Code NA
Dividend Yield(%)
Market Cap(Million)
P/E(X)
EPS(Rs.)
Face Value(Rs.)  
Type
(Rs. in Million)
ParticularsMar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Profit Before Tax-3306.50-642.75-757.66-1094.75660.45
Adjustment1443.10580.421093.711258.971340.52
Changes In working Capital2216.62337.735086.00830.842370.28
Cash Flow after changes in Working Capital353.22275.405422.05995.064371.25
Cash Flow from Operating Activities353.22275.405672.75795.694221.38
Cash Flow from Investing Activities-49.68-164.104040.01-1960.17-888.72
Cash Flow from Financing Activities-337.76-103.78-10153.32724.35-3377.95
Net Cash Inflow / Outflow-34.227.52-440.56-440.13-45.29
Opening Cash & Cash Equivalents71.8464.32504.87945.02990.33
Cash & Cash Equivalent on Amalgamation / Take over / Merger00000
Cash & Cash Equivalent of Subsidiaries under liquidations00000
Translation adjustment on reserves / op cash balalces frgn subsidiaries00000
Effect of Foreign Exchange Fluctuations00000
Closing Cash & Cash Equivalent37.6271.8464.31504.89945.04